Biotechnology Development Fund VI, L.P.
4
7M
4
0.22
1
1
- Stages of investment
- Areas of investment
Summary
In 2003 was created Biotechnology Development Fund VI, L.P., which is appeared as VC. The leading representative office of defined VC is situated in the Palo Alto. The fund was located in North America if to be more exact in United States.
This organization was formed by Edgar G. Engleman.
Among the most popular portfolio startups of the fund, we may highlight Pepgen Corporation. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular fund investment industries, there are Life Science, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2004.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Veron International, Valley Ventures, Toucan Capital.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.22
- Investments by industry
- Biotechnology (3)
- Medical (2)
- Clinical Trials (1)
- Pharmaceutical (1)
- Biopharma (1) Show 4 more
- Investments by region
-
- United States (3)
- United Kingdom (1)
- Peak activity year
- 2004
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 1.00
- Avg. company exit year
- 31
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Forbes Medi-Tech | 07 Jan 2004 | Biotechnology, Health Care, Life Science, Nutrition, Dietary Supplements | Early Stage Venture | 10M | United States, New Jersey |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.